Femasys Inc. (FEMY) Dividend History

Company News

• Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

  Femasys Inc. announced plans for a public offering of common stock and a concurrent private placement. The company intends to use the proceeds for expansion, product development, and general corporate purposes.

  Benzinga
• Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam

  Leading women’s reproductive health conference directly follows the company’s EU CE Mark approval for four of its products Leading women’s reproductive health conference directly follows the company’s EU CE Mark approval for four of its products

  GlobeNewswire Inc.
• Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

  Lee-Sepsick Discussed Company’s FemCerv® Endocervical Tissue Sampler and its Role in Cervical Cancer Diagnosis Lee-Sepsick Discussed Company’s FemCerv® Endocervical Tissue Sampler and its Role in Cervical Cancer Diagnosis

  GlobeNewswire Inc.
• Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council

  Lee-Sepsick Discussed Atlanta-Based Biomedical Company’s Women’s Reproductive Health Products Lee-Sepsick Discussed Atlanta-Based Biomedical Company’s Women’s Reproductive Health Products

  GlobeNewswire Inc.
• Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates

  Femasys (FEMY) delivered earnings and revenue surprises of 22.73% and 9.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: ATRA